Anti-CD11a treatment for psoriasis concurrently increases circulating T-cells and decreases plaque T-cells, consistent with inhibition of cutaneous T-cell trafficking

J Invest Dermatol. 2000 Aug;115(2):333. doi: 10.1046/j.1523-1747.2000.00abs-8.x.
No abstract available